Literature DB >> 7628982

Binding affinities of beta-lactam antibodies for penicillin-binding protein 2' in methicillin-resistant staphylococcus aureus.

Y Sumita1, M Fukasawa, S Mitsuhashi, M Inoue.   

Abstract

We devised an accurate procedure with which to measure the affinities of beta-lactam antibiotics for penicillin-binding protein (PBP) 2' in methicillin-resistant Staphylococcus aureus (MRSA). In the present study, we used two isogenic strains of MRSA, on heterogeneous and the other homogeneous, derived from the methicillin-susceptible strain FDA209P, harbouring the mecA gene. In these MRSA strains, PBP2' was saturated by [14C]benzylpenicillin (PCG) at a concentration of 300 mg/L. In addition, the saturation of PBP2' by [14C]PCG required an incubation period of 30 min. According to these results, the precise affinities of beta-lactam antibiotics for PBP2' were determined by the 'accurate competition assay', using a high concentration of [14C]PCG and extending the reaction time. This procedure yielded lower IC50 values of beta-lactams than the 'usual competition assay'. However, each beta-lactam had almost the same affinity for PBP2' in heterogeneous and homogeneous strains. These results suggest there is a factor(s) other than PBP2' responsible for controlling resistance levels and the heterogeneity or homogeneity of MRSA strains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7628982     DOI: 10.1093/jac/35.4.473

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Microtiter plate-based assay for inhibitors of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus.

Authors:  Sudheer Bobba; V K Chaithanya Ponnaluri; Mridul Mukherji; William G Gutheil
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

2.  Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole.

Authors:  Andrew L Lovering; Michael C Gretes; Susan S Safadi; Franck Danel; Liza de Castro; Malcolm G P Page; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

3.  In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.

Authors:  Yutaka Ueda; Katsunori Kanazawa; Ken Eguchi; Koji Takemoto; Yoshiro Eriguchi; Makoto Sunagawa
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Reaction of soluble penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus with beta-lactams and acyclic substrates: kinetics in homogeneous solution.

Authors:  K Graves-Woodward; R F Pratt
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

5.  In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.

Authors:  Yutaka Ueda; Makoto Sunagawa
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

6.  Potent in vitro activity of tomopenem (CS-023) against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Tetsufumi Koga; Nobuhisa Masuda; Masayo Kakuta; Eiko Namba; Chika Sugihara; Takashi Fukuoka
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.